NCT05257720View on ClinicalTrials.gov

Evaluation of the Role of Neurodegeneration in Schizophrenia

CompletedOBSERVATIONAL
Enrollment

178

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

August 1, 2022

Study Completion Date

October 1, 2022

Conditions
Schizophrenia
Interventions
DIAGNOSTIC_TEST

GFAP, S100B

It is planned to measure serum GFAP and S100 B protein levels by ELISA method.

Trial Locations (1)

34876

T.C. Sağlik Bilimleri Üniversitesi, Istanbul

All Listed Sponsors
lead

Istanbul Saglik Bilimleri University

OTHER